Why uniQure Stock Is Trading Lower After FDA Meeting Update

uniQure N.V. (NASDAQ:QURE) stock is trading lower on Thursday. • QURE shares are retreating from recent levels. Check the market position here.The gene therapy company received final meeting minutes from the U.S. Food and Drug Administration regarding a pre-Biologics License Application (BLA) meeting held in October to discuss the application for AMT-130, an investigational gene therapy for Huntington’s disease (HD). In the final meeting minutes, and consistent with uniQure’s November press release, the FDA ...